These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 27328446)

  • 21. Heart rate-lowering efficacy and respiratory safety of ivabradine in patients with obstructive airway disease: a randomized, double-blind, placebo-controlled, crossover study.
    Majewski S; Slomka S; Zielinska-Wyderkiewicz E; Ciebiada M; Gorski P
    Am J Cardiovasc Drugs; 2012 Jun; 12(3):179-88. PubMed ID: 22409211
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of ivabradine in patients with stable angina receiving β-blockers according to baseline heart rate: an analysis of the ASSOCIATE study.
    Tardif JC; Ponikowski P; Kahan T;
    Int J Cardiol; 2013 Sep; 168(2):789-94. PubMed ID: 23138014
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness of point-of-care oral ivabradine for cardiac computed tomography.
    Guler EC; Yam Y; Jia K; El Mais H; Hossain A; Chow BJW; Small GR
    J Cardiovasc Comput Tomogr; 2021; 15(3):226-231. PubMed ID: 33039320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heart rate in ischemic heart disease. The innovation of ivabradine: more than pure heart rate reduction.
    Rosano GM; Vitale C; Volterrani M
    Adv Ther; 2010 Apr; 27(4):202-10. PubMed ID: 20495895
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heart rate reduction after heart transplantation with beta-blocker versus the selective If channel antagonist ivabradine.
    Doesch AO; Celik S; Ehlermann P; Frankenstein L; Zehelein J; Koch A; Katus HA; Dengler TJ
    Transplantation; 2007 Oct; 84(8):988-96. PubMed ID: 17989604
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heart rate reduction by inhibition of If or by beta-blockade has different effects on postsystolic wall thickening.
    Lucats L; Ghaleh B; Colin P; Monnet X; Bizé A; Berdeaux A
    Br J Pharmacol; 2007 Feb; 150(3):335-41. PubMed ID: 17179940
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heart rate-reducing therapy with add-on ivabradine and bisoprolol before coronary computed tomographic angiography in a fast-track ambulatory setting.
    Muster V; Wallner M; Schmidt A; Kapl M; von Lewinski F; Rainer P; Reittner P; Tillich M; Brader P; Szolar DH; von Lewinski D
    J Int Med Res; 2018 Jun; 46(6):2249-2257. PubMed ID: 29614895
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ivabradine in stable coronary artery disease without clinical heart failure.
    Fox K; Ford I; Steg PG; Tardif JC; Tendera M; Ferrari R;
    N Engl J Med; 2014 Sep; 371(12):1091-9. PubMed ID: 25176136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and Safety of Ivabradine in Combination with Beta-Blockers in Patients with Stable Angina Pectoris: A Systematic Review and Meta-analysis.
    Nedoshivin A; Petrova PTS; Karpov Y
    Adv Ther; 2022 Sep; 39(9):4189-4204. PubMed ID: 35842897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ivabradine in the treatment of systolic heart failure - A systematic review and meta-analysis.
    Anantha Narayanan M; Reddy YN; Baskaran J; Deshmukh A; Benditt DG; Raveendran G
    World J Cardiol; 2017 Feb; 9(2):182-190. PubMed ID: 28289533
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ivabradine in acute coronary syndromes: Protection beyond heart rate lowering.
    Niccoli G; Borovac JA; Vetrugno V; Camici PG; Crea F
    Int J Cardiol; 2017 Jun; 236():107-112. PubMed ID: 28256323
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A meta-analysis of randomized controlled trials assessing the impact of beta-blockers on arterial stiffness, peripheral blood pressure and heart rate.
    Niu W; Qi Y
    Int J Cardiol; 2016 Sep; 218():109-117. PubMed ID: 27232921
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ivabradine: A Review of Labeled and Off-Label Uses.
    Oliphant CS; Owens RE; Bolorunduro OB; Jha SK
    Am J Cardiovasc Drugs; 2016 Oct; 16(5):337-47. PubMed ID: 27405864
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antianginal efficacy and tolerability of ivabradine in the therapy of patients with stable angina: results of the CONTROL study].
    Glezer MG; Saĭgitov RT
    Kardiologiia; 2010; 50(11):65-75. PubMed ID: 21526568
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Innovation in coronary artery disease and heart failure: clinical benefits of pure heart rate reduction with ivabradine.
    Canet E; Lerebours G; Vilaine JP
    Ann N Y Acad Sci; 2011 Mar; 1222():90-9. PubMed ID: 21434947
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does tight heart rate control improve beta-blocker efficacy? An updated analysis of the noncardiac surgical randomized trials.
    Beattie WS; Wijeysundera DN; Karkouti K; McCluskey S; Tait G
    Anesth Analg; 2008 Apr; 106(4):1039-48, table of contents. PubMed ID: 18349171
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ivabradine in combination with Beta-blockers in patients with chronic stable angina after percutaneous coronary intervention.
    Werdan K; Ebelt H; Nuding S; Höpfner F; Stöckl G; Müller-Werdan U
    Adv Ther; 2015 Feb; 32(2):120-37. PubMed ID: 25687888
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of ivabradine on central aortic blood pressure in patients with stable coronary artery disease: What do we know?
    Lopatin YM; Vitale C
    Int J Cardiol; 2016 Dec; 224():145-148. PubMed ID: 27657463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective Heart Rate Reduction With Ivabradine Increases Central Blood Pressure in Stable Coronary Artery Disease.
    Rimoldi SF; Messerli FH; Cerny D; Gloekler S; Traupe T; Laurent S; Seiler C
    Hypertension; 2016 Jun; 67(6):1205-10. PubMed ID: 27091900
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ivabradine in combination with beta-blocker reduces symptoms and improves quality of life in elderly patients with stable angina pectoris: age-related results from the ADDITIONS study.
    Müller-Werdan U; Stöckl G; Ebelt H; Nuding S; Höpfner F; Werdan K;
    Exp Gerontol; 2014 Nov; 59():34-41. PubMed ID: 25193811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.